Business Wire

Vasion ® Achieves FedRAMP ® High Authorization, Meeting Federal Cloud Security Gold Standard

18.2.2026 14:00:00 CET | Business Wire | Press Release

Share

Vasion, a leader in serverless printing and Intelligent Print Automation, today announced it has achieved FedRAMP® High Authorization to Operate (ATO) through the Federal Risk and Authorization Management Program. This authorization represents the most rigorous security compliance standard for the government sector.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218295773/en/

At V3, Vasion Co-Founder and CEO Ryan Wedig unveiled the Intelligent Print Automation platform and challenged every Vasioneer to embrace a Mission of Aspirational Performance that demands collaboration, creativity, and courage. With Vasion's recent FedRAMP High Authorization, the company is making digital transformation attainable for everyone, including federal agencies with the most stringent security requirements.

"First, I want to say thank you to DISA. They have been a longtime customer and powerful sponsor in helping us get through this multi-year, complex process," said Ryan Wedig, CEO and Co-Founder of Vasion. "Most of our customers know us for our ability to automate the challenges of physical print. This authorization unlocks something much bigger. It enables our customers with the highest security requirements to use our entire platform to securely automate both physically and digitally printed documents through complex, AI-driven workflows."

Vasion completed the authorization process with sponsorship from the Defense Information Systems Agency (DISA), which serves as a primary cybersecurity and IT infrastructure organization for the Department of Defense. This sponsorship underscores the strategic importance of Vasion's print and output automation capabilities for federal cloud-based operations.

The FedRAMP High Authorization validates that Vasion meets FedRAMP’s most rigorous security and compliance standards, providing data confidentiality, integrity, and availability across mission-critical U.S. government operations.

“The foundation for this authorization started in 2016 when we made a strategic decision to rebuild the platform from the ground up to be cloud native, multi-tenant, and fully immutable," said Corey Ercanbrack, Chief Technology Officer at Vasion. "While many competitors hosted their legacy on-premise products and called it SaaS, we built cloud native. That architecture is why we achieved FedRAMP High with a platform built for it, not retrofitted. Federal agencies now have an intelligent print automation solution for all their physical and digital print workflows with single-click integration to the latest AI models.”

The FedRAMP High authorization positions Vasion to serve government agencies requiring FedRAMP authorized cloud services for their document processes and critical print operations. Vasion already incorporates enterprise-grade security features, including ISO 42001, ISO 27001 and SOC 2 certifications, advanced encryption, and comprehensive audit trails that align with federal security requirements.

About Vasion

Vasion is the intelligent print automation platform making digital transformation attainable for all by eliminating print servers, consolidating print environments, and digitizing workflows. We’re redefining modern output management with the world’s most advanced and secure cloud-native platform, turning what’s been IT’s longest-standing headache, print, into a strategic advantage. More than 13,500 global customers, including hundreds of the world’s leading enterprises, rely on Vasion to modernize and unlock AI-ready environments. With Vasion, digital transformation works for everyone. Learn more at www.vasion.com.

About FedRAMP

The Federal Risk and Authorization Management Program (FedRAMP) is a government wide program that provides a standardized approach to security assessment, authorization, and continuous monitoring for cloud products and services. Established in 2011, FedRAMP promotes the adoption of secure cloud services across the federal government by providing a "do once, use many" approach to cloud security authorizations. For more information, visit fedramp.gov.

Vasion, Vasion Output, and the Vasion logo are trademarks or registered trademarks of Vasion, Inc. in the United States and other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260218295773/en/

Contacts

Nadia Romero
Sr. Manager of PR and Corporate Communications
nadia.romero@vasion.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye